close

Agreements

Date: 2017-09-20

Type of information: Opening of new premises

Compound: research laboratories in Genopole

Company: Enterome Bioscience (France)

Therapeutic area: Autoimmune diseases - Inflammatory diseases - Digestive diseases - Cancer - Oncology

Type agreement: opening of new premises

Action mechanism:

Disease:

Details:

  • • On September 20, 2017, Enterome announced that the company is moving its research laboratories to Genopole, a leading biocluster dedicated to biotechnology and research in genomics and genetics. The new laboratories brings Enterome closer to its existing and potential new partners and provides opportunities to extend its scientific expertise and network to develop its business further.
  • About 15 of the 40 people employed by Enterome will work permanently at Genopole in laboratories dedicated to the discovery and development of innovative therapeutic products derived from the gut microbiome.
 

Financial terms:

Latest news:

Is general: Yes